Your browser doesn't support javascript.
loading
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
Orcurto, Angela; Hottinger, Andreas; Wolf, Benita; Navarro Rodrigo, Blanca; Ochoa de Olza, Maria; Auger, Aymeric; Kuntzer, Thierry; Comte, Denis; Zimmer, Virginie; Gannon, Philippe; Kandalaft, Lana; Michielin, Olivier; Zimmermann, Stefan; Harari, Alexandre; Trueb, Lionel; Coukos, George.
Afiliación
  • Orcurto A; Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland angela.orcurto@chuv.ch.
  • Hottinger A; Oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Wolf B; Service of Neurology, Department of Clinical Neurosciences, CHUV, Lausanne, Vaud, Switzerland.
  • Navarro Rodrigo B; Oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Ochoa de Olza M; Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Auger A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland.
  • Kuntzer T; Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Comte D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland.
  • Zimmer V; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland.
  • Gannon P; Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Kandalaft L; Service of Neurology, Department of Clinical Neurosciences, CHUV, Lausanne, Vaud, Switzerland.
  • Michielin O; Service of Immunology and Allergy, Department of Medicine, CHUV, Lausanne, Vaud, Switzerland.
  • Zimmermann S; Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Harari A; Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
  • Trueb L; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland.
  • Coukos G; Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland.
J Immunother Cancer ; 8(2)2020 08.
Article en En | MEDLINE | ID: mdl-32847987
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfocitos Infiltrantes de Tumor / Síndrome de Guillain-Barré Tipo de estudio: Guideline Límite: Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfocitos Infiltrantes de Tumor / Síndrome de Guillain-Barré Tipo de estudio: Guideline Límite: Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido